Increased inflammation and insulin resistance are commonly observed in obesity and diabetes. Inflammatory mediators secreted by the adipose tissue contribute to the pathogenesis of diabetes and cardiovascular diseases. Free fatty acids and pro-inflammatory cytokines from adipose tissue inhibit the intracellular insulin signaling pathway, further contributing to the progression of diabetes. Meta-analysis studies show that high sensitivity C-reactive protein can be used as a predictor of future all-cause mortality, including cardiovascular and cancer mortality. In addition to the discovery of novel therapeutic methods targeting inflammatory mediators, basic lifestyle interventions, such as regular exercise, healthy eating, and proper weight control, are absolutely crucial for reducing inflammation and preventing mortality.
Citations
Citations to this article as recorded by
Molecular and pathophysiological intersections between arterial hypertension, pulmonary inflammation and diabetes mellitus Higo José Neri da Silva, Antônio Carlos Melo Lima-Filho, Ester Miranda Pereira, Ian Jhemes Oliveira Sousa, Francisco Valmor Macedo Cunha, Massimo Lucarini, Alessandra Durazzo, Leonardo da Rocha Sousa, Daniel Dias Rufino Arcanjo Frontiers in Pharmacology.2026;[Epub] CrossRef
Stimulation, regulation, and inflammaging interventions of natural compounds on nuclear factor kappa B (NF-kB) pathway: a comprehensive review Gowtham Kannan, Benedict Mathews Paul, Parimelazhagan Thangaraj Inflammopharmacology.2025; 33(1): 145. CrossRef
Links between oral microbiome and insulin resistance: Involvement of MAP kinase signaling pathway Yi-Ru Chang, Wen-Chi Cheng, Ya-Chun Hsiao, Guan-Wei Su, Shan-Jen Lin, Yu-Shan Wei, Hsiu-Chuan Chou, Hsiu-Ping Lin, Guan-Yu Lin, Hong-Lin Chan Biochimie.2023; 214: 134. CrossRef